Ureteral stone. Calculus of lower urinary tract
Conditions
Interventions
Intervention 1: Treatment group, Double G, along with the use of Teolite with the generic name of Theophylline Retard with a dose of 200 mg, Obeidi Pharmaceutical Company, 30 tablets, one daily for on
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Patients undergoing trans ureteral lithotripsy Patients under the endoscopic ureter For other cases that have a bleeding effect, double G is installed for them. Written and informed consent from patients
Exclusion criteria
Exclusion criteria: Symptoms of prostatitis/ asthma/ being a smoker Diabetes Gastrointestinal discomfort Insomnia and tremors Taking potassium-sparing diuretics Taking digoxin in patients with heart problems Taking levodopa Taking calcium supplements at the same time/ Taking spironolactone tablets Previous history of hyperkalemia Taking triamterene Taking tablets Amiloride High blood potassium and pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigating the double J infection brought on by double J stent placement and theophylline usage or non-use. Timepoint: Immediately after leaving double J stent. Method of measurement: Laboratory diagnosis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematuria after surgery from the operation site. Timepoint: Immediately after surgery. Method of measurement: The number of wet gases. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Akram Mirzaei
Tehran University of Medical Sciences
Outcome results
None listed